$245.52
2.30% today
NYSE, Apr 02, 10:00 pm CET
ISIN
US0905722072
Symbol
BIO
Sector

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Stock price

$245.52
-10.93 4.26% 1M
-97.10 28.34% 6M
-82.99 25.26% YTD
-83.20 25.31% 1Y
-324.03 56.89% 3Y
-115.22 31.94% 5Y
+108.49 79.17% 10Y
NYSE, Closing price Wed, Apr 02 2025
+5.52 2.30%
ISIN
US0905722072
Symbol
BIO
Sector

Key metrics

Market capitalization $6.72b
Enterprise Value $6.43b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 22.26
EV/Sales (TTM) EV/Sales 2.51
P/S ratio (TTM) P/S ratio 2.62
P/B ratio (TTM) P/B ratio 1.02
Revenue growth (TTM) Revenue growth -3.92%
Revenue (TTM) Revenue $2.57b
EBIT (operating result TTM) EBIT $331.47m
Free Cash Flow (TTM) Free Cash Flow $289.00m
Cash position $1.67b
EPS (TTM) EPS $-65.04
P/S forward 2.63
EV/Sales forward 2.52
Short interest 5.78%
Show more

Is Bio-Rad Laboratories Inc. - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Bio-Rad Laboratories Inc. - Ordinary Shares - Class A forecast:

6x Buy
67%
3x Hold
33%

Analyst Opinions

9 Analysts have issued a Bio-Rad Laboratories Inc. - Ordinary Shares - Class A forecast:

Buy
67%
Hold
33%

Financial data from Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,567 2,567
4% 4%
100%
- Direct Costs 1,173 1,173
5% 5%
46%
1,393 1,393
3% 3%
54%
- Selling and Administrative Expenses 617 617
0% 0%
24%
- Research and Development Expense 252 252
12% 12%
10%
524 524
11% 11%
20%
- Depreciation and Amortization 193 193
6% 6%
8%
EBIT (Operating Income) EBIT 331 331
14% 14%
13%
Net Profit -1,844 -1,844
189% 189%
-72%

In millions USD.

Don't miss a Thing! We will send you all news about Bio-Rad Laboratories Inc. - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Head office United States
CEO Norman Schwartz
Employees 7,700
Founded 1952
Website www.bio-rad.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today